聖元環保(300867.SZ):全資子公司擬投資11.66億元建設化學藥品(食品)原料及食品、藥品健康產業項目
格隆匯5月14日丨聖元環保(300867.SZ)公佈,公司於2024年5月14日召開第九屆董事會2024年第三次會議,審議並通過了《關於全資子公司投資建設化學藥品(食品)原料及食品、藥品健康產業項目的議案》,同意以下屬全資子公司分別進行化學藥品(食品)原料及食品、藥品健康產業項目的投資建設。
公司下屬全資子公司泉州聖元生物科技工程有限公司擬在福建省泉州市泉港區石化工業園區投資建設化學藥品(食品)原料項目,其中,首期投資7.49億元人民幣先行建設年產4萬噸牛磺酸項目,以開展化學藥品(食品)原料牛磺酸及相關產品的研發、生產和銷售。該項目已基本完成前期準備工作,項目目前正在辦理安全預評價、主體工程施工許可證等手續。
公司下屬全資子公司泉州聖元康健藥業有限公司擬在福建省泉州市泉港區前黃鎮開展牛磺酸在食品、藥品、保健品、寵物食品及飼料應用領域項目的生產線建設。該項目投資額約3.97億元人民幣。
本次擬投資建設項目及前期生產項目投入合計總投資為人民幣11.66億元,資金來源為公司自籌資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.